Efficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndrome

scientific article published on 14 July 2016

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/TCRM.S108965
P932PMC publication ID4948739
P698PubMed publication ID27471389

P2093author name stringXin Wang
Huidong Wang
P2860cites workEffects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevationQ28188284
Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE)Q28213517
Ticagrelor versus clopidogrel in patients with acute coronary syndromesQ29619002
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND studyQ34021458
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of CardiolQ34288425
Review of the treatment of acute coronary syndrome in elderly patientsQ37448924
P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.Q37562606
Antiplatelet therapy in older adults with non-ST-segment elevation acute coronary syndrome: considering risks and benefitsQ37583089
Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.Q38243032
Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: an open-label, sequential, two-cohort, single-centre studyQ38479485
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of GerQ40213069
Trends in aging--United States and worldwide.Q40599470
Predictors of hospital mortality in the global registry of acute coronary eventsQ42611826
Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudyQ42910350
Comparison of bleeding and in-hospital mortality in Asian-Americans versus Caucasian-Americans with ST-elevation myocardial infarction receiving reperfusion therapyQ44210206
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.Q44928926
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) triaQ46068914
Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative.Q50685933
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics studyQ53461746
Third Universal Definition of Myocardial InfarctionQ56627595
Acute Coronary Care in the Elderly, Part IQ57483864
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsQ73854850
Acute coronary syndromes in the elderlyQ83254743
???Q22242895
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P921main subjectclopidogrelQ410237
P304page(s)1101-1105
P577publication date2016-07-14
P1433published inTherapeutics and Clinical Risk ManagementQ15766913
P1476titleEfficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndrome
P478volume12

Reverse relations

cites work (P2860)
Q64238125Analysis of Ticagrelor's Cardio-protective Effects on Patients with ST-segment Elevation Acute Coronary Syndrome Accompanied with Diabetes
Q59799852Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
Q64228092Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
Q100503955Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis
Q48294015Efficacy and safety of ticagrelor in patients with acute coronary syndrome: A meta-analysis of randomized controlled trials
Q49540317Evaluation of pharmacokinetic, pharmacodynamic, efficacy, and safety data of low-dose ticagrelor versus standard dose in East Asians: a systematic review
Q89992913Ticagrelor for Asian patients with acute coronary syndrome in real-world practice: A systematic review and meta-analysis of observational studies
Q41265471Update on pharmacological treatment of acute coronary syndrome without persistent ST segment elevation myocardial infarction in the elderly

Search more.